V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270018079 | 270009178 | 1.7 | 52.2 | Not known (9) | 2013-09-01 | 2013-09-06 | Rituximab (Maintenance) | N | N | 270015218 | RITUXIMAB |
| 270018080 | 270014294 | 1.82 | 89.45 | Curative (C) | 2017-01-12 | 2017-01-27 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 270015224 | CISPLATIN + RT |
| 270018081 | 270018323 | null | 68 | Curative (C) | 2017-05-02 | 2017-05-02 | LEAM | 2 | N | 270015225 | LEAM |
| 270018082 | 270009183 | 1.62 | 55 | Curative (C) | 2017-08-25 | 2017-08-25 | Rituximab | N | N | 270015226 | RITUXIMAB |
| 270018083 | 270009188 | null | 92.9 | Curative (C) | 2015-11-24 | 2016-11-17 | LEAM | null | null | 270015236 | LEAM |
| 270018084 | 270009193 | 1.58 | 49.1 | Adjuvant (A) | 2016-01-13 | 2016-02-11 | OEPA | N | N | 270015246 | OEPA |
| 270018085 | 270009194 | 1.57 | 84.6 | Disease modification (D) | 2017-08-27 | 2017-09-15 | Rituximab | N | N | 270015247 | RITUXIMAB |
| 270018086 | 270009195 | 1.68 | 85.8 | Palliative (P) | 2014-12-07 | 2014-12-07 | Mini BEAM | 01 | N | 270015247 | BEAM |
| 270018088 | 270009198 | 1.8 | 50.6 | Palliative (P) | 2015-07-16 | 2015-07-22 | CETUXIMAB + IRINOTECAN + MDG | N | null | 270015252 | CETUXIMAB + IRINOTECAN + MDG |
| 270018089 | 270009201 | 1.77 | null | Curative (C) | 2017-02-02 | 2017-02-17 | CISPLATIN + RT | N | N | 270015254 | CISPLATIN + RT |
| 270018090 | 270009205 | 1.76 | 71 | Palliative (P) | 2016-01-20 | 2016-12-18 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015269 | CETUXIMAB + IRINOTECAN + MDG |
| 270018091 | 270009210 | 1.84 | 63.5 | Curative (C) | 2017-11-11 | 2017-11-12 | BEAM | 02 | N | 270015275 | BEAM |
| 270018092 | 270018327 | 1.73 | 20.8 | Disease modification (D) | 2017-06-07 | 2017-06-15 | LEAM | N | Y | 270015276 | LEAM |
| 270018093 | 270009214 | null | 97 | Curative (C) | null | 2015-07-27 | ESHAP | 2 | Y | 270015286 | ESHAP |
| 270018094 | 270009217 | 1.49 | 52.2 | Curative (C) | 2015-06-07 | 2015-06-07 | CETUXIMAB + IRINOTECAN + MDG | 99 | null | 270015293 | CETUXIMAB + IRINOTECAN + MDG |
| 270018095 | 270009220 | 1.81 | 71.4 | Curative (C) | 2016-11-23 | 2017-01-05 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015300 | CETUXIMAB + IRINOTECAN + MDG |
| 270018097 | 270016858 | 1.69 | 84.4 | Curative (C) | 2014-07-13 | 2014-07-13 | OEPA | 02 | N | 270015309 | OEPA |
| 270018098 | 270020156 | 1.7 | 47.4 | null | 2015-09-22 | 2016-04-21 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015310 | CETUXIMAB + IRINOTECAN + MDG |
| 270018099 | 270009231 | 0 | 62.4 | Curative (C) | 2016-09-26 | 2016-10-26 | OEPA | N | N | 270015319 | OEPA |
| 270018100 | 270009232 | 1.69 | 77.55 | Not known (9) | 2014-06-19 | 2014-07-10 | CISPLATIN + RT | 02 | N | 270015322 | CISPLATIN + RT |
| 270018101 | 270014316 | 1.61 | null | null | 2017-11-27 | 2017-11-27 | Rituximab | N | N | 270015329 | RITUXIMAB |
| 270018102 | 270009235 | 1.76 | 22 | Curative (C) | 2018-03-14 | 2018-05-03 | Rituximab | N | null | 270015330 | RITUXIMAB |
| 270018103 | 270016863 | 1.76 | 68.8 | Palliative (P) | 2015-05-16 | 2015-07-18 | BEAM | N | N | 270015333 | BEAM |
| 270018104 | 270009239 | 0 | null | Palliative (P) | 2017-10-11 | 2017-10-25 | Cetuximab + FOLFIRI cycle1 | 02 | N | 270015338 | CETUXIMAB + IRINOTECAN + MDG |
| 270018105 | 270009241 | 1.66 | 63.7 | null | 2016-12-21 | 2017-02-01 | ESHAP | 2 | null | 270015339 | ESHAP |
| 270018106 | 270009244 | 1.68 | 68 | Neo-adjuvant (N) | 2015-02-05 | 2016-07-08 | ESHAP | null | null | 270015342 | ESHAP |
| 270018107 | 270014319 | null | 109 | Palliative (P) | 2013-05-08 | 2013-05-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | 270015350 | CETUXIMAB + IRINOTECAN + MDG |
| 270018108 | 270009247 | 1.56 | 62.8 | Curative (C) | 2013-05-16 | 2013-05-29 | Cisplatin + Radiotherapy | 99 | null | 270015351 | CISPLATIN + RT |
| 270018109 | 270018337 | 1.88 | 105 | Curative (C) | 2017-09-09 | 2017-09-15 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 270015353 | CISPLATIN + RT |
| 270018110 | 270009253 | 1.73 | 52.4 | null | 2018-05-03 | 2018-05-14 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 270015366 | CISPLATIN + RT |
| 270018111 | 270009260 | 0 | 90 | Palliative (P) | 2017-10-17 | 2017-10-18 | BEAM | N | null | 270015393 | BEAM |
| 270018112 | 270019184 | null | 119.6 | Not known (9) | 2016-12-14 | 2017-01-07 | Fluorouracil + Folinic Acid Weekly | N | null | 270015404 | FLUOROURACIL |
| 270018113 | 270014328 | 1.61 | 100 | Palliative (P) | 2015-02-04 | 2015-05-01 | Trifluridine + Tipiracil | N | N | 270015405 | TRIFLURIDINE + TIPIRACIL |
| 270018114 | 270014328 | 1.79 | 25.4 | Curative (C) | null | 2016-07-28 | CETUXIMAB + RT | null | null | 270015405 | CETUXIMAB + RT |
| 270018115 | 270009268 | 1.69 | 88.7 | Adjuvant (A) | 2018-07-29 | 2018-08-03 | Cetuximab + Radiotherapy Load | 2 | N | 270015420 | CETUXIMAB + RT |
| 270018116 | 270009269 | 1.71 | 75.4 | Palliative (P) | 2014-08-20 | 2014-08-25 | Fluorouracil + Folinic Acid Weekly | null | null | 270015422 | FLUOROURACIL |
| 270018117 | 270014332 | 1.66 | 52.5 | Palliative (P) | 2018-01-26 | 2018-01-26 | FLUOROURACIL | N | N | 270015445 | FLUOROURACIL |
| 270018118 | 270009276 | null | 119.6 | Palliative (P) | 2017-03-07 | 2017-12-22 | Capecitabine 42days + RT | 02 | N | 270015458 | CAPECITABINE + RT |
| 270018119 | 270014335 | 1.66 | 82.8 | Curative (C) | 2016-03-19 | 2016-03-24 | DHAP | 2 | null | 270015462 | DHAP |
| 270018120 | 270016878 | 1.74 | 67 | null | 2018-09-19 | 2018-09-21 | CHLVPP | N | N | 270015465 | CHLVPP |
| 270018121 | 270009284 | 1.77 | 95.4 | Neo-adjuvant (N) | 2013-10-04 | 2015-05-09 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270015466 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270018122 | 270009289 | null | null | Palliative (P) | 2017-05-03 | 2017-06-20 | DHAP | N | N | 270015482 | DHAP |
| 270018123 | 270009291 | 1.77 | 44.6 | Palliative (P) | 2016-06-17 | 2016-07-16 | CHLVPP | 02 | null | 270015483 | CHLVPP |
| 270018124 | 270009297 | 1.66 | 60 | Palliative (P) | 2017-09-10 | 2017-09-10 | Cisplatin +Fluorouracil (3 wk) | N | N | 270015489 | CISPLATIN + FLUOROURACIL |
| 270018125 | 270009299 | 1.79 | 64 | Palliative (P) | 2015-09-03 | 2015-09-07 | Capecitabine (21 day) + Irinotecan | null | null | 270015490 | CAPECITABINE + IRINOTECAN |
| 270018126 | 270009299 | null | 80 | Palliative (P) | 2014-09-27 | 2014-10-01 | DHAP | null | null | 270015490 | DHAP |
| 270018127 | 270009306 | 1.66 | 181 | Palliative (P) | null | 2015-12-14 | CHLVPP | N | N | 270015509 | CHLVPP |
| 270018128 | 270009307 | 1.49 | 94 | Palliative (P) | 2018-05-12 | 2018-05-20 | CAPECITABINE + IRINOTECAN | N | N | 270015510 | CAPECITABINE + IRINOTECAN |
| 270018129 | 270009308 | 1.62 | 100.8 | Palliative (P) | 2017-06-05 | 2017-06-06 | Capecitabine 35days + RT | 2 | N | 270015514 | CAPECITABINE + RT |
| 270018130 | 270009313 | null | null | Palliative (P) | 2016-04-02 | 2016-04-17 | CAPECITABINE + IRINOTECAN | N | N | 270015522 | CAPECITABINE + IRINOTECAN |